Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/pbc.29049 http://scihub22266oqcxt.onion/10.1002/pbc.29049 33955167!8206673!33955167     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Pediatr+Blood+Cancer 2021 ; 68 (7): e29049 Nephropedia Template TP {{tp|p=33955167|t=2021. How we approach thrombosis risk in children with COVID-19 infection and MIS-C |pdf=|usr=}}{{33955167}} gab.com Text How we approach thrombosis risk in children with COVID-19 infection and MIS-C JO: Pediatr Blood Cancer http://www.kidney.de/pget.php?&tw=1&pmid=33955167 #FOAvip Thrombosis within the microvasculature and medium to large vessels is a serious and common complication among critically ill individuals with coronavirus disease 2019 (COVID-19). While children are markedly less likely to develop severe disease than adults, they remain at risk for thrombosis during acute infection and with the post-acute inflammatory illness termed multisystem inflammatory syndrome in children. Significant knowledge deficits in understanding COVID-19-associated coagulopathy and thrombotic risk pose clinical challenges for pediatric providers who must incorporate expert opinion and personal experience to manage individual patients. We discuss clinical scenarios to provide framework for characterizing thrombosis risk and thromboprophylaxis in children with COVID-19. Twit Text FOAVip How we approach thrombosis risk in children with COVID-19 infection and MIS-C ????Pediatr Blood Cancer http://www.kidney.de/pget.php?&tw=1&pmid=33955167 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33955167 #FOAvip English Wikipedia <ref>{{Cite pmid|33955167}}</ref> How we approach thrombosis risk in children with COVID-19 infection and MIS-C #MMPMID33955167 Sharathkumar AA; Faustino EVS; Takemoto CM Pediatr Blood Cancer 2021[Jul]; 68 (7): e29049 PMID33955167show ga Thrombosis within the microvasculature and medium to large vessels is a serious and common complication among critically ill individuals with coronavirus disease 2019 (COVID-19). While children are markedly less likely to develop severe disease than adults, they remain at risk for thrombosis during acute infection and with the post-acute inflammatory illness termed multisystem inflammatory syndrome in children. Significant knowledge deficits in understanding COVID-19-associated coagulopathy and thrombotic risk pose clinical challenges for pediatric providers who must incorporate expert opinion and personal experience to manage individual patients. We discuss clinical scenarios to provide framework for characterizing thrombosis risk and thromboprophylaxis in children with COVID-19. |*COVID-19 Drug Treatment[MESH] |*COVID-19/blood[MESH] |*Systemic Inflammatory Response Syndrome/blood/drug therapy[MESH] |*Thrombosis/blood/drug therapy[MESH] |Adolescent[MESH] |Anticoagulants/*administration & dosage[MESH] |Child[MESH] |Female[MESH] |Humans[MESH] |Male[MESH]How we approach thrombosis risk in children with COVID-19 infection an(epmc).pdf DeepDyve Pubget Overpricing